Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Multiple Myeloma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Laryngeal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 25Cetuximab 12Radiotherapy 11Docetaxel 11Fluorouracil 9Carboplatin 9Surgical Procedures, Operative 8Radiotherapy, Intensity-Modulated 8pembrolizumab 7Magnetic Resonance Spectroscopy 7Radiation 6Surveys and Questionnaires 5Specimen Handling 5Drug Therapy 5toripalimab 4Standard of Care 4Celecoxib 41,2-diaminocyclohexaneplatinum II citrate 4X-Rays 3Platinum 3Paclitaxel 3Nutritional Status 3Interviews as Topic 3Hydroxyurea 3Counseling 3Biopsy 3130-nm albumin-bound paclitaxel 3Taxes 2Resistance Training 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Laryngeal Neoplasms × gossypol acetic acid × Clear all
NCT01633541 2023-07-20

Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer

University of Michigan Rogel Cancer Center

Phase 2 Completed
55 enrolled 15 charts
Head & Neck

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡